Table 1.
Antibiotic resistance phenotypes of E. coli strains isolated from CA-UTIs in Romania.
| Antibiotic | GR A | GR B1 | GR B2 | GR D | Number (percentage) |
|---|---|---|---|---|---|
| AMP | 90 (52.94%) | 98 (45.16%) | 125 (45.28%) | 66 (53.65%) | 374 (47.52%) |
| TET | 75 (44.11%) | 91 (41.93%) | 98 (35.50%) | 61 (49.59%) | 324 (41.16%) |
| SXT | 43 (25.29%) | 52 (23.96%) | 60 (21.73%) | 41 (33.33%) | 192 (24.39%) |
| AMC | 38 (22.35%) | 41 (18.89%) | 55 (19.92%) | 24 (19.51%) | 151 (19.18%) |
| CFZ | 35 (20.58%) | 29 (13.36%) | 42 (15.21%) | 17 (13.82%) | 122 (15.50%) |
| CIP | 34 (20%) | 38 (17.51%) | 28 (10.14%) | 18 (14.63%) | 118 (14.99%) |
| LEV | 34 (20%) | 38 (17.51%) | 28 (10.14%) | 18 (14.63%) | 117 (14.86%) |
| ATM | 16 (9.41%) | 21 (9.67%) | 27 (9.78%) | 11 (8.94%) | 79 (10.03%) |
| FEP | 16 (9.41%) | 21 (9.67%) | 26 (9.42%) | 10 (8.13%) | 73 (9.27%) |
| CRO | 16 (9.41%) | 21 (9.67%) | 26 (9.42%) | 10 (8.13%) | 72 (9.14%) |
| TZP | 17 (10%) | 11 (5.06%) | 16 (5.79%) | 3 (2.43%) | 47 (5.97%) |
| CN | 12 (7.05) | 6 (2.76%) | 10 (3.62%) | 7 (5.69%) | 34 (4.32%) |
| NIT | 5 (2.94%) | 8 (3.68%) | 7 (2.53%) | 4 (3.25%) | 24 (3.04%) |
| IMP | 0 | 0 | 0 | 1 (0.81%) | 1 (0.12%) |
| MEM | 0 | 0 | 0 | 0 | 0 |
| ETP | 0 | 0 | 0 | 0 | 0 |
AMP, ampicillin; TET, tetracycline; SXT, trimethoprim-sulfamethoxazole; AMC, amoxicillin-clavulanic acid; CFZ, cefazolin; CIP, ciprofloxacin; LEV, levofloxacin; ATM, aztreonam; FEP, cefepime; CRO, ceftriaxone; TZP, piperacillin-tazobactam; CN, gentamicin; NIT, nitrofurantoin; IMP, imipenem; MEM, meropenem; ETP, ertapenem.